Uterine neoplasms, version 3.2021 featured updates to the NCCN guidelines

Nadeem R. Abu-Rustum, Catheryn M. Yashar, Kristin Bradley, Susana M. Campos, Junzo Chino, Hye Sook Chon, Christina Chu, David Cohn, Marta Ann Crispens, Shari Damast, Elisabeth Diver, Christine M. Fisher, Peter Frederick, David K. Gaffney, Suzanne George, Robert Giuntoli, Ernest Han, Brooke Howitt, Warner K. Huh, Jayanthi LeaAndrea Mariani, David Mutch, Larissa Nekhlyudov, Mirna Podoll, Steven W. Remmenga, R. Kevin Reynolds, Ritu Salani, Rachel Sisodia, Pamela Soliman, Edward Tanner, Stefanie Ueda, Renata Urban, Stephanie L. Wethington, Emily Wyse, Kristine Zanotti, Nicole R. McMillian, Angela D. Motter

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations

Abstract

The NCCN Guidelines for Uterine Neoplasms provide recommendations for diagnostic workup, clinical staging, and treatment options for patients with endometrial cancer or uterine sarcoma. These NCCN Guidelines Insights focus on the recent addition of molecular profiling information to aid in accurate diagnosis, classification, and treatment of uterine sarcomas.

Original languageEnglish (US)
Pages (from-to)889-895
Number of pages7
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume19
Issue number8
DOIs
StatePublished - Aug 2021

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Uterine neoplasms, version 3.2021 featured updates to the NCCN guidelines'. Together they form a unique fingerprint.

Cite this